Hawaii · 2026 Regular Session · Concurrent Resolution
SCR 18: REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SCR 18 is a concurrent resolution introduced in the Hawaii Senate on February 6, 2026. According to its official title, it concerns: REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION. Primary sponsor: Kurt Fevella (Republican), Jarrett Keohokalole (Democratic). Most recent recorded action (March 30, 2026): The committee on HHS deferred the measure.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1 · Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Kurt Fevella | Primary sponsor | Republican | Senate | 20 |
| Jarrett Keohokalole | Primary sponsor | Democratic | Senate | 24 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- The committee on HHS deferred the measure.
- The committee(s) on HHS has scheduled a public hearing on 03-30-26 1:07PM; Conference Room 225 & Videoconference.
- Referred to HHS, WAM.
- Offered.